Nav: Home

First states to expand Medicaid saw larger screening rate increases

May 22, 2019

A new study examining Medicaid expansion and cancer screening finds that the five states and District of Columbia that first adopted Medicaid expansion saw larger increases in colorectal cancer (CRC) screening than those states that did not expand Medicaid. The study, appearing early online in the American Journal of Preventive Medicine, estimates that if non-expansion states had experienced the same increase in recent colorectal cancer screening as the very early expansion states, an additional 355,184 people would have been screened.

The Affordable Care Act (ACA) was enacted in 2010 and provided federal support for states to expand Medicaid insurance coverage to low-income adults, a group with limited access to preventive services. Five states and the District of Columbia were very early adopters and expanded Medicaid eligibility in 2010?2011. An additional twenty-one states expanded their Medicaid programs during 2014; five states expanded in 2015-2016 and 19 states did not expand.

To find out whether the timing of Medicaid expansion improved screening prevalence, the current study, led by Stacey A. Fedewa, Ph.D., senior principal scientist in the Surveillance and Health Services Research department at the American Cancer Society, examined temporal changes in screening patterns among low-income adults in all states, using data from the 2012, 2014, and 2016 Behavioral Risk Factor Surveillance System (BRFSS), a state-based telephone survey overseen by the Centers for Disease Control and Prevention (CDC).

Between 2012 and 2016, the proportion of low-income adults ages 50 to 64 who were up-to-date with CRC screening grew by 8.8 percentage points in very early adopters (from 42.3% to 51.1%), by 2.9 percentage points in early adopters (from 49.6% to 52.5%), and by 3.8 percentage points in non-expansion states (from 44.2% to 48.0%). The magnitude of this change was greatest in very early versus non-expansion states. Recent CRC screening (defined as having a colonoscopy, stool testing or sigmoidoscopy in the past two years) increased by 8 percentage points (from 30.1% to 38.1%) in very early states and 2.8 percentage points (from 29.1% to 31.8%) in non-expansion states. The improvement in screening rates in very early expansion states translated to an additional 236,573 low-income adults receiving recent CRC screening in 2016. If the same absolute increase was experienced in non-expansion states, 355,184 more low-income adults would have had recent CRC screening than what was observed.

"Health insurance is a strong predictor of cancer screening, and the uninsured and those with lower socioeconomic status are more likely to be diagnosed at late stage and die from screen-detectable cancers, including colorectal cancer," said Dr. Fedewa.

The authors note that the growth in CRC screening prevalence in the very early expansion states was not immediate and that changes in CRC screening among those expanding Medicaid later were comparable to non-expansion states. That may reflect the lag time between people gaining insurance and completing the multistep screening process that typically relies on a physician visit, followed by a recommendation, and then a follow-up visit with a specialist if a colonoscopy is performed.

"It is likely that the full impact of Medicaid expansions on cancer screening may not yet be fully visible and the previously reported modest improvements in early stage at diagnosis for screen detectable cancers could progress further," write the authors.

They also found breast cancer screening increased only modestly among low-income women residing in expansion states. That could be due to more widespread and historical support for mammography in low income populations through initiatives like CDC's National Breast and Cervical Cancer Early Detection Program, as well as programs offered by non-profits, and mobile mammography clinics. Also, mammography has far fewer financial and logistic barriers than colonoscopy as it is cheaper and requires less preparation.
-end-
Article: Changes in Breast and Colorectal Cancer Screening After Medicaid Expansion Under the Affordable Care Act, Stacey A. Fedewa, Robin Yabroff, Robert Smith, Ann Goding Sauer, Xuesong Han, Ahmedin Jemal, Am J Prevent Med 2019 doi: 10.1016/j.amepre.2019.02.015

URL after embargo: https://doi.org/10.1016/j.amepre.2019.02.015

American Cancer Society

Related Colorectal Cancer Articles:

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.
Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.
A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.
Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.
Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.
Aspirin before at-home colorectal cancer screening test didn't significantly improve ability to detect cancer precursors
Some observational studies have suggested that taking aspirin before undergoing colorectal cancer screening with a fecal immunochemical test for blood in stool might improve the ability of the test to detect cancer precursors.
Gene involved in colorectal cancer also causes breast cancer
Rare mutations in the NTHL1 gene, previously associated with colorectal cancer, also cause breast cancer and other types of cancer.
Bug that causes stomach cancer could play a role in colorectal cancer
A bacterium known for causing stomach cancer might also increase the risk of certain colorectal cancers, particularly among African Americans, according to a study led by Duke Cancer Institute researchers.
'Chromosomal catastrophes' in colorectal cancer
'Chromosomal catastrophes' have been found to occur along the evolutionary timeline of colorectal cancer development, according to new research led by Queen Mary University of London.
Colorectal cancer: Tipping the scales
Tumors of the colon are among the most prevalent cancers.
More Colorectal Cancer News and Colorectal Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.